Eli Lilly is leading the GLP-1 charge, but investors have already priced much of the good news into the stock.
Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...
INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025. David A. Ricks, Lilly chair and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results